National survey of imaging practice for suspected or confirmed plasma cell malignancies
Olwen Westerland(St Thomas' Hospital), Vicky Goh(King's College London), Guy Pratt(University Hospitals Birmingham NHS Foundation Trust), Martin Sambrook(Royal College of Radiologists), Matthew Streetly(King's College - North Carolina), Kwee Yong(CRUK Lung Cancer Centre of Excellence), Rakesh Mehan(Royal College of Radiologists), David Silver(Royal College of Radiologists), Monica Morris(Myeloma UK), Inas El‐Najjar(Guy's and St Thomas' NHS Foundation Trust), Majid Kazmi, Margaret Hall‐Craggs(University College London Hospitals NHS Foundation Trust)
Cited by 11
Related Papers
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
|The Lancet|2020|366
Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma
|Journal of Clinical Oncology|2004|315
Guidelines for the diagnosis and management of multiple myeloma 2011
|British Journal of Haematology|2011|305